News

Dresden-Hellerau, 14th February 2020. Biotype is looking forward to the attendance at the ’40th Spurenworkshop’ (forensic stain analysis workshop) of the German Society of Legal Medicine (DGRM) and the German Forensic Stain Commission in Munich. ...

Dresden-Hellerau, 30th October 2019. From November 11 to 13, we will attend the Bio-Europe 2019, Europe’s largest biotechnology partnering conference. Once again, pharmaceutical, financial and biotechnology companies will meet in Hamburg to develop ...

Dresden-Hellerau, 1st October 2019. Biotype launches three new assays on its molecular diagnostic platform MODAPLEXTM: Modaplex KRAS Mutation Analysis Kit Modaplex NRAS Mutation Analysis Kit Modaplex BRAF Mutation Analysis Kit The kits (research use only) ...

From Sept. 27 to Oct. 1, we will be at Europe’s largest oncology congress, the ESMO Congress 2019. This year, clinicians, researchers and industry representatives will meet in Barcelona to discover the newest updates and insights on oncology. Biotype ...

Dresden-Hellerau, June 28th 2019. We are excited to announce that Biotype Diagnostic GmbH and Biotype Innovation GmbH have decided to merge their capabilities to form one strong entity. The two biotech companies have been close cooperation partners for ...

Dresden-Hellerau, February 13th 2019. Our cooperation partner BIOTYPE is expanding its product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation ...

Biotype Diagnostic expands highly specific CE-IVD portfolio for chimerism monitoring Dresden-Hellerau, 07 February 2019. Biotype Diagnostic GmbH, in response to customer demand, now offers the qPCR kit Mentype® DIPquant as an in-vitro diagnostic with ...

Dresden-Hellerau, 02 November 2018. After launching two assays for MSI and POLE/POLD1 analysis this year, Biotype Innovation introduces its first CE-IVD certified test kit running on the Modaplex system. The Modaplex Clostridium difficile Analysis Kit ...

Biotype Innovation’s contract development service for molecular diagnostic innovations is expanding. Since our inauguration in April 2015, we offer integrated solutions that are customized to your requirements, including development, manufacture, and ...

Dresden-Hellerau, June 19, 2017. Just two years after its foundation and a year after the lab inauguration, Biotype Innovation successfully launches its first four products. The company developed a unique FGFR panel (fibroblast growth factor receptor) ...